Madrigal Pharmaceuticals Inc (MDGL)

Other Income/Expenses (Net)

-$2.48M

TTM · Period ending: · USD

MDGL logo

MDGL Other Income/Expenses (Net)

Latest reported-$2.48M
MDGL TTM Other Income/Expenses (Net) ($641.00K → -$2.48M)
High-resolution chart · PNG

MDGL other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Madrigal Pharmaceuticals Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-2,480,000
4,072,000
11,813,000
18,359,000
27,914,000
33,559,000
31,982,000
29,384,000
19,838,000
9,922,000
6,866,000
1,278,000
699,000
-408,000
-1,779,000
-1,121,000
-276,000
272,000
636,000
1,016,000
1,779,000
2,992,000
4,429,000
6,211,000
8,154,000
9,855,000
11,024,000
11,789,000
11,844,000
10,205,000
7,871,000
5,358,000
2,811,000
1,537,000
908,000
375,525
12,303
-317,697
-1,368,697
-1,458,222
-18,117,000
-18,175,000
-17,575,000
-17,877,000
-1,646,000
-1,935,000
-2,210,000
-2,470,000
-2,674,000
-2,813,000
-2,633,000
-31,592,000
-31,328,000
-31,090,000
-31,106,000
-38,570,000
-38,629,000
-38,636,000
-38,585,000
-30,546,000
-30,061,000
-29,598,000
-29,213,000
85,957,000
85,935,000
43,965,000
43,951,000
-108,870,000
-108,687,000
-66,434,000
-65,575,000
-104,559,000
-104,170,000
-103,698,000
-104,116,000
-44,503,000
-45,373,000
-46,098,000
-46,475,000
-351,000
0
0
641,000
-942,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.